Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv, Israel.
J Biol Chem. 2013 Jul 5;288(27):19649-60. doi: 10.1074/jbc.M113.464974. Epub 2013 May 23.
DNA damage can occur due to environmental insults or intrinsic metabolic processes and is a major threat to genome stability. The DNA damage response is composed of a series of well coordinated cellular processes that include activation of the DNA damage checkpoint, transient cell cycle arrest, DNA damage repair, and reentry into the cell cycle. Here we demonstrate that mutant cells defective for TOR complex 2 (TORC2) or the downstream AGC-like kinase, Gad8, are highly sensitive to chronic replication stress but are insensitive to ionizing radiation. We show that in response to replication stress, TORC2 is dispensable for Chk1-mediated cell cycle arrest but is required for the return to cell cycle progression. Rad52 is a DNA repair and recombination protein that forms foci at DNA damage sites and stalled replication forks. TORC2 mutant cells show increased spontaneous nuclear Rad52 foci, particularly during S phase, suggesting that TORC2 protects cells from DNA damage that occurs during normal DNA replication. Consistently, the viability of TORC2-Gad8 mutant cells is dependent on the presence of the homologous recombination pathway and other proteins that are required for replication restart following fork replication stalling. Our findings indicate that TORC2 is required for genome integrity. This may be relevant for the growing amount of evidence implicating TORC2 in cancer development.
DNA 损伤可能由于环境因素的侵害或内在代谢过程而产生,是基因组稳定性的主要威胁。DNA 损伤反应由一系列协调良好的细胞过程组成,包括 DNA 损伤检查点的激活、短暂的细胞周期停滞、DNA 损伤修复以及重新进入细胞周期。在这里,我们证明了 TOR 复合物 2(TORC2)或下游 AGC 样激酶 Gad8 突变的细胞对慢性复制应激非常敏感,但对电离辐射不敏感。我们表明,在复制应激下,TORC2 对于 Chk1 介导的细胞周期停滞是可有可无的,但对于恢复细胞周期进程是必需的。Rad52 是一种 DNA 修复和重组蛋白,在 DNA 损伤部位和停滞的复制叉处形成焦点。TORC2 突变细胞显示自发核 Rad52 焦点增加,特别是在 S 期,这表明 TORC2 保护细胞免受正常 DNA 复制过程中发生的 DNA 损伤。一致地,TORC2-Gad8 突变细胞的生存能力依赖于同源重组途径和其他在复制叉复制停滞后用于复制重新启动的蛋白质的存在。我们的发现表明,TORC2 对于基因组完整性是必需的。这可能与越来越多的证据表明 TORC2 参与癌症的发展有关。